Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition containing, as active ingredient, fusion protein in which tumor-penetrating peptide and anti-angiogenesis agent are fused, for preventing and treating cancer or angiogenesis-related diseases

Pharmaceutical composition containing, as active ingredient, fusion protein in which tumor-penetrating peptide and anti-angiogenesis agent are fused, for preventing and treating cancer or angiogenesis-related diseases

US Patent 10919947 · Granted Feb 16, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ingot growth apparatus2025
Systems and methods for workspace recommendations2025
Building data platform with digital twin based predictive recommendation visuali2025
Predictive modeling and control system for building equipment with multi-device 2025
Building data platform with digital twin triggers and actions2025
Building management system with generative AI-based automated flexible customer 2025
Building management systems and methods for tuning fault detection thresholds2025
Building data platform with digital twin functionality indicators2025
Heterodimeric Fc-fused cytokine and pharmaceutical composition comprising the sa2025
Apparatus, method and recording medium for receiving four-level pulse amplitude 2025
Automated technologies for assessing and certifying the safety of AI-based produ2025
CH3 domain variant pair inducing formation of heterodimer of heavy chain constan2025